Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix
- 1 November 2001
- Vol. 92 (9) , 2471-2483
- https://doi.org/10.1002/1097-0142(20011101)92:9<2471::aid-cncr1597>3.0.co;2-k
Abstract
The incidence of adenocarcinoma of the uterine cervix is increasing. For better prognostic information, the authors studied all nonsquamous cell carcinomas (non-SCCs) in the Norwegian population over a total of 15 years. All non-SCCs from three 5-year periods (1966–1970, 1976–1980, and 1986–1990) were reviewed and classified according to the World Health Organization classification system, and histopathologic and clinical parameters were registered. Tissue blocks were available from all patients. Of 505 patients, 417 had tumors classified as adenocarcinoma, and 88 had tumors classified as other non-SCC. The mean ages were 53 years and 52 years for patients with adenocarcinoma and non-SCC, respectively. Sixty-two percent of the staged patients had clinical Stage I disease according to the classification system of the International Federation of Gynecology and Obstetrics (FIGO). In univariate analyses, histology, architectural and nuclear grade, extension to the vagina or corpus uteri, tumor length (> 20 mm) or tumor volume (> 3000 mm3), infiltration depth (in thirds of the cervical wall), thickness of the remaining wall (< 3 mm), vascular invasion, lymph node metastases, treatment, and patient age were significant variables in patients with FIGO Stage I disease. Variables with no significance in patients with Stage I disease were number of mitoses, state of resection margins, infiltration to ectocervix, tumor thickness, lymphoid reaction, earlier or concomitant cervical intraepithelial neoplasia, stump carcinoma, DNA ploidy or DNA index, or time period. Multivariate analyses of patients with FIGO Stage I disease identified small cell carcinoma, corpus infiltration, vascular invasion, and positive lymph nodes as independent prognostic factors. Small cell carcinoma was the only histologic subgroup of independent importance for prognosis in patients with non-SCC of the uterine cervix. No significant difference between major subtypes of adenocarcinoma favored a simplified classification. Extension to the corpus in patients with early-stage disease was of independent significance and should be acknowledged in planning treatment. Cancer 2001;92:2471–83. © 2001 American Cancer Society.Keywords
This publication has 38 references indexed in Scilit:
- Prognostic Factors of Adenocarcinoma of the Uterine CervixGynecologic Oncology, 1999
- Are adenocarcinomas and adenosquamous carcinomas different from squamous carcinomas in stage IB and II cervical cancer patients undergoing primary radical surgery?International Journal of Gynecologic Cancer, 1999
- An Analysis of Cell Type in Patients with Surgically Staged Stage IB Carcinoma of the Cervix: A Gynecologic Oncology Group StudyGynecologic Oncology, 1996
- Prognosis and prognostic factors in node-negative cervix cancerInternational Journal of Gynecologic Cancer, 1996
- No Prognostic Impact of Flow-Cytometric Measured DNA Ploidy and S-Phase Fraction in Cancer of the Uterine Cervix: A Prospective Study of 465 PatientsGynecologic Oncology, 1995
- Influence of HSP27 and steroid receptor status on provera sensitivity, DNA-ploidy and survival of females with endometrial cancerInternational Journal of Gynecologic Cancer, 1995
- Incidence, survival and mortality in cervical cancer in Norway, 1956–1990European Journal Of Cancer, 1993
- Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapseAmerican Journal of Obstetrics and Gynecology, 1993
- Adenocarcinoma of the uterine cervix: Prognostic factors and patterns of recurrenceGynecologic Oncology, 1989
- Adenocarcinoma of the uterine cervixGynecologic Oncology, 1982